Registration Details
The British Toxicology Society (BTS) and British Pharmacology Society (BPS) are hosting a one day online meeting to explore the opportunities and challenges associated with the increasing use of artificial intelligence (AI) throughout the process of developing a new medicine, considering both efficacy and safety.
Topics
The use of AI for:
- Drug discovery.
- Drug development.
- Clinical and regulatory assessment of drugs.
Learning objectives
- Raise awareness of the current use of AI in drug development.
- Highlight opportunities and challenges for the future use of AI in drug development.
- Facilitate dialogue on next steps for the research community, bridging academia, industry, regulation and healthcare sectors.
Find out more about our work in this area and watch the recording of a webinar jointly hosted by the NC3Rs NAMs Network and the BTS Mechanistic & Discovery Toxicology Specialty Section: Artificial intelligence in safety assessment: Perspectives for the future.